---

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

---

 

FORM 8-K

 

---

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities

Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 22, 2004

 

---

 

MICROSEMI CORPORATION

(Exact name of Registrant as specified in its charter)

 

---

 

Delaware		0-8866		95-2110371
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

 

2381 Morse Avenue, Irvine, California		92614
(Address of principal executive office)		(Zip Code)

 

Registrant’s telephone number, including area code (949) 221-7100

 

Not Applicable

(Former name or former address, if changed, since last report)

 

---

---

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits

 

(c) Exhibits.

 

99.1		News Release dated July 22, 2004 relating to the Registrant’s earnings

 

Item 9. Regulation FD Disclosure.

 

(This information is furnished pursuant to this Item 9 and Item 12. Results of Operations and Financial Condition)

 

On April 22, 2004, the Registrant is publicly issuing a News Release, which is attached hereto as Exhibit 99.1 and incorporated herein by reference, relating to the Registrant’s earnings.

---

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

		MICROSEMI CORPORATION
		(Registrant)
Date: July 22, 2004		By:		David R. Sonksen
				David R. Sonksen,
				Executive Vice President, Chief Financial Officer, Treasurer and Secretary